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Background:  Regions  undergoing  maturation  with  CB1  receptors  may  be at  increased  risk  for  cannabis-
induced  alterations.  Here,  we  examine  the relationships  between  cannabis  use  and  prefrontal  (PFC)  and
inferior  parietal  gyriﬁcation  and  surface  area  (SA)  in youth.
Methods:  Participants  included  33  cannabis  users  and  35  controls  (ages  18–25).  Exclusions  included  co-
morbid  psychiatric/neurologic  disorders  and  heavy  other  drug  use. Multiple  regressions  and  Pearson  r
correlations  examined  the  effects  of cannabis  use  on gyriﬁcation,  SA  and cognition.
Results: Cannabis  use  was  associated  with  decreased  gyriﬁcation  in: ventral-medial  PFC (RH:  [FDR  cor-
rected p =  .02],  LH:  [FDR  corrected  p = .02]);  medial  PFC  (RH:  [FDR  corrected  p  = .02],  LH:  [FDR  corrected
p  =  .02]);  and  frontal  poles  (RH:  [FDR  corrected  p  = .02],  LH:  [FDR  corrected  p =  .02]).  No  differences  were
observed  in  bilateral  hemispheres,  PFC,  dorsolateral,  ventrolateral,  or inferior  parietal  ROIs.  Cannabis  use
was associated  with  marginally  decreased  SA  in  left:  medial  PFC  [FDR  corrected  p  = .09],  and ventral  lat-
eral  PFC:  [FDR  corrected  p  = .09].  In cannabis  users,  increased  gyriﬁcation  was associated  with improved
working-memory  performance  in  right medial  (p =  .003),  ventral-medial  (p  = .03),  and  frontal  pole  ROIs
(p =  .007).
Conclusions: Cannabis  use was associated  with  reduced  gyriﬁcation  in  PFC  regions  implicated  in self-
referential  thought  and  social  cognition.  Results  suggest  that  these  gyriﬁcation  characteristics  may  have
cognitive  implications.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Cannabis is the second most used drug after alcohol, with
2.9% of high school seniors and 20% of college students using
n the past month, and perhaps most alarmingly, one in every
5 seniors reporting daily use (Johnston et al., 2014). Cannabis
egislation changes are sweeping across the United States. Policy
xperts predict that increased access and reduced price will lead
o increased usage, especially in young adults who are the heav-
est users (Caulkins et al., 2012). Late adolescence and emerging
dulthood is a period of ongoing neurodevelopment, with pruning
f inefﬁcient gray matter connections (Gogtay et al., 2004; Gogtay
nd Thompson, 2010). Healthy adult rats demonstrate enhanced
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878-9293/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
binding of cannabinoid (CB1) receptors within areas such as the
prefrontal cortex (PFC) (Verdurand et al., 2011) in comparison
to juveniles, suggesting increased reliance upon the cannabinoid
system with age. Indeed, converging lines of animal and human
evidence have suggested that this is a sensitive period that may  be
particularly vulnerable to cannabis-induced neurocognitive effects
(Jager and Ramsey, 2008; Meier et al., 2012; see Lisdahl et al., 2013
for review).
Preclinical animal models suggest that endogenous endo-
cannabinoid signaling in the PFC inﬂuences executive functioning
(EF) performance (for review see Egerton et al., 2006). In humans,
signiﬁcant CB1 receptor density has been measured in the PFC, a
region associated with mood regulation and EF, and throughout
the cortex (Goldberg, 2009; Terry et al., 2009; see Yurgelun-Todd,
2007). Therefore, disruption of the endogenous cannabinoid sys-
tem during adolescence may  particularly impact the integrity later
developing regions, such as the PFC and parietal lobes (Gogtay
et al., 2004; Gogtay and Thompson, 2010). Indeed, daily cannabis
users demonstrate signiﬁcant, though reversible, downregulation
of the CB1 density in PFC and other cortical regions including
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
tal Cog
t
y
i
(
L
h
a
t
r
p
o
s
a
p
e
m
e
l
d
w
o
a
t
m
(
R
H
m
a
e
s
n
s
t
i
t
s
r
f
s
t
d
a
l
O
c
i
F
v
e
2
f
a
b
c
a
s
(
c
g
2
d
i
cS.G. Shollenbarger et al. / Developmen
he parietal lobes (Hirvonen et al., 2012). Further, cannabis-using
outh demonstrate impairments in executive functioning, includ-
ng complex attention, inhibitory control, and working memory
Harvey et al., 2007; Hanson et al., 2010; Medina et al., 2007;
isdahl and Price, 2012).
Previous structural magnetic resonance imaging (MRI) research
as demonstrated that regular (weekly or more) cannabis using
dolescents demonstrate larger PFC (including orbitofrontal cor-
ex) volume in female cannabis users (Medina et al., 2009) and
educed medial orbitofrontal volumes in a primarily male sam-
le (Churchwell et al., 2010). Our group has found reduced medial
rbitofrontal (mOFC) and inferior parietal volumes in this same
ample of young adults (Price et al., 2015) compared to controls,
nd other groups have found that earlier age of onset signiﬁcantly
redicted decreased right superior PFC thickness (Lopez-Larson
t al., 2011). Recent MRI  advances have yielded new measure-
ents of cortical architecture that may  be more sensitive to drug
ffects than volume or cortical thickness. One such candidate is
ocal gyriﬁcation index, or a 3-dimensional ratio representing the
egree of folding on the outer surface relative to buried cortex
ithin neighboring sulci, which may  also be calculated for regions
f interest (Schaer et al., 2008, 2012). Several candidate theories
ttempt to explain the primary driving mechanisms of gyriﬁca-
ion development, including cortico-cortical mechanical tension,
orphogenetic, and differential cortical expansion rate inﬂuences
Richman et al., 1975; see Van Essen, 1997; Toro and Burnod, 2005;
onan et al., 2013; Tallinen et al., 2014; see Kriegstein et al., 2006;
ilgetag and Barbas, 2006; White et al., 2010 for reviews). Another
easure is cortical surface area (SA), which is a reﬂection of the
mount of area on the cortical surface represented in mm2 (Dale
t al., 1999).
Age-related changes in cortical surface area (SA) and other
urface characteristics, including gyral and sulcal shape, have been
oted in several preliminary studies. Schnack et al. (2015) mea-
ured SA changes between MRI  scans in 504 subjects. Results from
he study found age-related changes in SA such that adolescence
s a period in which the cortex is greatly expanding and reaches
he maximum individual peak in SA during this time. Further, the
ame study found that those with the highest IQ had the greatest
ate of cortical SA change during this period. Magnotta et al. (1999)
ound a signiﬁcant relationship between age with gyral and sulcal
hape in a sample of 148 participants aged 18–82. A more recent
wo-year longitudinal study with 52 participants found overall
ecreases in gyriﬁcation index in youth who were between the
ges of 11 and 17 at baseline, with signiﬁcant widening of sulci and
oss of SA within the frontal cortex (Alemán-Gómez et al., 2013).
ther samples have found reduced PFC surface complexity in teens
ompared to children (Su et al., 2013), and reduced PFC gyriﬁcation
n young adults compared to early teens (Klein et al., 2014).
urther, increased gyriﬁcation has been associated with enhanced
ocabulary knowledge in typically developing youth (Wallace
t al., 2013). In a large cohort of 322 healthy adults spanning ages
0–85, SA decreases were most robust within the dorsomedial
rontal, and PFC gyriﬁcation decreases were observed with older
ge (Hogstrom et al., 2012). Sex differences in folding have also
een noted with females demonstrating greater gyriﬁcation in PFC
ompared to males (Luders et al., 2004; Mutlu et al., 2013). Lastly,
 large longitudinal study in 647 participants found an inverted-U
haped trajectory of SA maturation between the ages of 3 and 30
Raznahan et al., 2011). Changes in SA appeared to peak later than
ortical thickness in the large cohort. The same study found that
yriﬁcation index (note: this index differs from the Schaer et al.,
008 LGI measure) and convex hull area inﬂuence SA changes
uring early to late adolescents; however, late adolescent changes
n SA may  be most attributed by reductions in gyriﬁcation in
omparison to reduced convex hull area. Further, SA may  peak atnitive Neuroscience 16 (2015) 46–53 47
later developmental periods compared to other cortical measures
such as volume (Wierenga et al., 2014). Preliminary evidence
suggests that later developing regions, such as the PFC (Gogtay
et al., 2004), continue to undergo gyriﬁcation, cortical surface
shape, and SA changes during adolescents and young adulthood.
While several studies have demonstrated a great degree of
genetic inﬂuences on cortical thickness, gray, and white matter
volume (see Douet et al., 2014), studies of gyriﬁcation or surface
characteristics among small samples of monozygotic (MZ) twins
demonstrate observable differences (Bartley et al., 1997; Biondi
et al., 1998; Mohr et al., 2004; White et al., 2002), suggesting that
environmental factors may  inﬂuence the shape of the cortical sur-
face (see White et al., 2010) especially in secondary and tertiary
sulci (Lohmann et al., 1999). For example, Hasan et al. (2011) found
that PFC gyriﬁcation was  no more similar in MZ  twins compared to
dizygotic twins. Therefore, compared to other brain characteristics,
such as gray and white matter volume, surface morphometry val-
ues (including gyriﬁcation) appear to be signiﬁcantly inﬂuenced by
environmental factors compared to genetics, although this needs
to be conﬁrmed in larger sample sizes.
Therefore, gyriﬁcation may  reﬂect changes sensitive to repeated
behavioral or environmental inﬂuences, such as substance use,
although additional research in emerging adults is needed. To our
knowledge, only one study has examined surface morphology in
a sample of young cannabis users (Mata et al., 2010). Mata et al.
(2010) examined sulcal concavity, a measure similar yet distinct
from a 3-dimensional gyriﬁcation value. The study noted decreased
sulcal concavity in the left PFC and bilateral temporal lobes of
young adult cannabis users compared to controls (Mata et al., 2010).
The study also failed to ﬁnd any signiﬁcant differences in global
SA after controlling for potential confounds, suggesting a unique
characteristic of sulcal curvature differences in regions undergoing
neuromaturation in young cannabis users (Mata et al., 2010). The
same study did not examine sub-regional differences in SA or how
sulcal differences between cannabis users and non-users relate to
downstream behavioral phenotypes, such as neuropsychological
function.
Because cannabis use has an age of onset (SAMHSA, 2014) that
overlaps with continued PFC gyriﬁcation development (Su et al.,
2013; Klein et al., 2014), examining the impact of cannabis use on
gyriﬁcation remains an important area to investigate. The current
study examined whether cannabis use status predicted PFC or pari-
etal gyriﬁcation in a sample of adolescents and emerging adults.
Surface morphology may  be related to cortical thickness and vol-
ume  (Alemán-Gómez et al., 2013). Given that both reductions in
cortical thickness and volume (Lopez-Larson et al., 2011; Price et al.,
2015) and reductions in PFC sulcal concavity (Mata et al., 2010)
were previously found in young cannabis users, we predicted that
cannabis users would demonstrate reduced gyriﬁcation and SA in
PFC and parietal regions. Reduced SA and gyriﬁcation may be most
pronounced in both inferior frontal and parietal regions that show
reductions in volume (Churchwell et al., 2010; Price et al., 2015)
Within regions that differed between cannabis users and controls,
follow-up analyses examined brain–behavior relationships in both
groups.
2. Materials and methods
2.1. Participants
Participants included 68 (33 cannabis-users, 35 controls) right-
handed adolescents and emerging adults between the ages of
18–25 (21 male and 12 female cannabis-users; 15 male and
20 female controls) from a larger imaging genetics study (PI:
Lisdahl, NIH R03 DA027457). Exclusion criteria included MRI
4 tal Cognitive Neuroscience 16 (2015) 46–53
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Table 1
Demographic, substance use information according to group.
Cannabis users
(n = 33)
M (SD) [range]
Controls
(n = 35)
M (SD) [range]
Age 21.21 (2.34)
[18–25]
21.14 (2.33)
[18–25]
%  Female 36.4% 57.1%
%  Caucasian 66.7% 65.7%
WRAT-4 Reading
Standard Score
103.36 (15.86)
[73–134]
101.37 (10.13)
[81–120]
Education 13.12 (1.75)
[9–17]
13.91 (1.72)
[11–18]
Beck Depression
Inventory Total-2*
5.12 (3.84)
[0–17]
3.31 (3.39)*
[0–14]
Past  year nicotine use** 1788.67
(2532.57)
[0–7350]
455.86 (1093.0)
[0–3680]
Cotinine levels** 3.87 (2.39)
[0–6]
1.29 (2.08)
[0– 6]
Past year alcohol use** 282.91 (382.10)
[0–1724]
101.8 (166.38)
[0–878]
Past  year marijuana use** 548.36 (771.07)
[26–3895]
.40 (1.22)
[0–5]
Past year other drug use** 9.82 (30.31)
[0–171]
.11 (.53)
[0–3]
Notes: ANOVAs and Chi-squares tests assessed group differences; *p < .05; **p < .01.
On average, cannabis users reported increased depressive symptoms, higher cotinine
levels, and increased past year drug and alcohol use. Drug use categories were as
follows: nicotine (including cigarettes, chewing tobacco/snuff/pipe, cigars/hookah),
alcohol, MJ, and ‘other’ drug use, which was a total in standardized units (hits or8 S.G. Shollenbarger et al. / Developmen
ontraindications; history of chronic medical or neurologic ill-
ess or injury (meningitis, HIV, epilepsy, brain tumor, traumatic
rain injury, >2 min  of unconsciousness and concussion symptoms,
troke, cerebral palsy, Parkinson’s disease, Huntington’s disease,
igh blood pressure, diabetes, chronic migraines); history of a
earning disability; complications during birth/premature birth;
renatal exposure to alcohol (>4 drinks/day or >7 drinks/week) or
llicit drugs (>10 uses); current use of psychoactive medication;
reexisting DSM-IV Axis I disorders independent of substance use;
urrent pregnancy; >20 lifetime use occasions of any of the follow-
ng drug categories (stimulants, ecstasy, inhalants, hallucinogens,
edatives, or opiates); and refusal to remain abstinent from all drugs
nd alcohol for at least seven days. Individuals that classiﬁed as very
eavy alcohol drinkers (>8 standard drinks per week on average)
ere also excluded. Eligible participants consisted of two  groups,
annabis users (>25 past year and >50 lifetime joints) and controls
≤5 past year and <15 lifetime joints). Groups were matched as
losely as possible on age, education, ethnicity, gender, and verbal
Q.
.2. Procedures
The Institutional Review Board at the University of Cincinnati
pproved all aspects of this study. Participants were recruited
hrough advertisements in a local free newspaper and ﬂiers. Those
nterested were screened by phone for exclusionary criteria, which
ave been described in further detail elsewhere (see Price et al.,
015; Lisdahl and Price, 2012). Brieﬂy, a semi-structured interview
ased on DSM-IV-TR criteria for Axis I psychotic, anxiety, and mood
isorders was administered (see First et al., 2001). Next, eligible
articipants completed either one or two sessions. Those with mod-
rate or greater substance use completed the questionnaires, drug
se interview, neuropsychological battery, and MRI scan in two
essions (typically 2–3 days apart; see biological samples below).
articipants were paid $160 for two sessions (5.5 h) ($110 for one,
.5 h) and received parking reimbursement, local substance treat-
ent resources and images of their brain.
.3. Screening inventories and questionnaires
.3.1. Demographic information
Participants completed a Background Questionnaire outlining
emographic variables (see Table 1).
.3.2. Biological samples
Participants were administered a urine toxicology screen using
he One Step Drug Screen Test, a breathalyzer test, and female par-
icipants were administered a pregnancy test. Those who  tested
ositive for drugs and/or alcohol except cannabis and nicotine were
xcluded. Metabolite levels were further examined for participants
hat tested positive for cannabis via mass spectrometry testing.
ession 2 total THC metabolite ratios, controlling for creatinine,
ere subtracted from session 1 total ratios to ensure there were
o increases or current use while in the study (see Goodwin et al.,
008). Thus, if the difference in ratios reached >50 ng/mL, the par-
icipant was excluded. Cotinine levels measured recent nicotine use
r exposure.
.3.3. Drug use
Past year drug use was measured using a modiﬁed version of the
ime-Line Follow-Back (Sobell et al., 1979) interview (see Table 1
or categories). Drug use was measured by the number of standard
nits (cigarettes or cigars for nicotine; standard drinks for alco-
ol; joints for cannabis; tablets for ecstasy; grams for stimulants;
umber of hits or pills for inhalants, hallucinogens, and opioids;
nd pills or hits for sedatives). The Customary Drinking and Drugpills) including all of the following categories: stimulants, ecstasy, inhalants, hallu-
cinogens, sedatives, and opioids.
Use Record (CDDR), measured lifetime and past 3-month substance
use, withdrawal symptoms, DSM-IV abuse and dependence crite-
ria, and substance-related difﬁculties (Brown et al., 1998; Stewart
and Brown, 1995).
2.3.4. Self-reported mood
The Beck Depression Inventory-II (Beck et al., 1996) assessed
current depressive symptomology.
2.4. Neuropsychological assessments
2.4.1. Premorbid verbal intelligence/quality of education
The Wide Range Achievement Test-4th edition (WRAT-4) Read-
ing subtest (Wilkinson, 2006) measured estimates of verbal
intelligence and quality of education for group comparison pur-
poses (see Manly et al., 2002).
2.4.2. Complex attention
Complex attention was  assessed using the total correct
responses in the Wechsler Adult Intelligence Scale – Third Edi-
tion (WAIS-III) Letter Number Sequencing (LNS) and the Paced
Auditory Serial Attention Test (PASAT). The LNS is a subscale of
the WAIS-III Working Memory Index and measures the ability to
retain and manipulate bits of information over several separate
trials (Wechsler, 1997). The PASAT is a working memory task in
which participants must retain two  serially presented numbers and
perform a summation roughly every 2 s (Gronwall, 1977). LNS and
PASAT total scores were used for the current study.
2.4.3. Cognitive inhibition
The D-KEFS Color Word Interference Test Inhibition conditiontotal completion time assessed inhibitory ability (Delis and Kaplan,
2000). For this task, participants were required to read the color of
ink a color word is printed in (inhibition condition).
tal Cognitive Neuroscience 16 (2015) 46–53 49
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Fig. 1. ROI’s of cannabis users with signiﬁcantly reduced LGI and the correspond-S.G. Shollenbarger et al. / Developmen
.5. MRI  data acquisition
.5.1. Parameters
T1-weighted, 3-D SPGR anatomical brain scans were obtained
n a 4T Varian Unity MRI  scanner using a modiﬁed driven
quilibrium Fourier transform (MDEFT) sequence (FOV = 25.6 cm,
56 × 256 × 192 matrix, slice thickness = 1 mm,  in-plane res-
lution = 1 × 1 mm,  TR = 13 ms,  TE = 5.3 ms,  ﬂip angle = 22◦). A
euroradiologist at the Center for Imaging Research reviewed
natomical scans, and participants with noted abnormalities were
xcluded from this sample.
.6. MRI  processing
.6.1. PFC local gyriﬁcation analysis
Images were preprocessed in FreeSurfer version 5.3 (Dale et al.,
999). Average local gyriﬁcation indices (LGI) were created using
 radius set to 20 mm for each region listed below, in order
o maximize sensitivity (Schaer et al., 2008, 2012), and cortical
urface-based anatomical atlas (Destrieux et al., 2010). Regions of
nterest (ROIs) included bilateral: dorsal lateral PFC (DLPFC); medial
FC (mPFC); frontal pole; ventral medial PFC (vmPFC); ventral lat-
ral PFC (vlPFC); and inferior parietal (infPariet). Control regions
eﬂecting the average LGI and SA for each of the left and right
emispheres was included to test whether results were diffuse or
peciﬁc to a priori deﬁned ROIs.
.6.2. Surface area analysis
As part of the FreeSurfer processing stream (Dale et al., 1999) SA
as computed for each participant. Corresponding with the ROIs
isted above in the LGI analysis (see Section 2.6.1), SA was calculated
or all ROIs and the hemisphere control regions.
.6.3. Operating system
Mac  Pro with: OS X version 10.6.8, 12GB of memory, and
×2.26 GHz Quad-Core Intel Xeon.
.7. Statistical analyses
All analyses were conducted using SPSS. ANOVAs,
ann–Whitney U-test (drug variables), and Chi-square tests
ere run to examine potential demographic differences as well as
ifferences in past year drug use histories between drug groups.
ariables that either signiﬁcantly differed between groups or may
mpact neural architecture were entered as covariates (Medina
t al., 2007, 2008). Covariates included WRAT-4 Reading scaled
core, age, gender, past year alcohol use, cotinine levels, and
urrent depressive symptoms.
General linear modeling (GLM) in SPSS was used to examine
hether cannabis group status was signiﬁcantly associated with
 priori deﬁned LGI or SA ROIs. Standard least squares multiple
egression was  used; block one included covariates, and block two
ncluded cannabis group status. All dependent variables were nor-
ally distributed and there was no evidence of multicollinearity.
igniﬁcance was determined if p < .05, and correction for multiple
omparisons was calculated for each hemisphere’s results utilizing
enjamini and Hochberg’s False Discovery Rate correction (FDR;
enjamini and Hochberg, 1995). All FDR corrections were com-
uted for the left and right hemispheres separately.
In the cannabis users, Pearson r correlations were run between
ognitive performance (complex attention and cognitive inhibi-
ion; see Price et al., 2015) and gyriﬁcation or SA ROIs that
igniﬁcantly differed between groups. Signiﬁcance was  determined
f p < .05 (after FDR correction).ing p values and FDR corrected p values corrected for multiple comparisons. Note:
yellow = medical PFC; blue = frontal pole; orange = ventral medial PFC; Lh = left hemi-
sphere; Rh = right hemisphere; LGI = local gyriﬁcation index.
3. Results
3.1. Demographic and mood information
3.1.1. Demographic and self-report variables
ANOVAs and Chi-squares were run to test differences between
cannabis users and controls. There were signiﬁcant differences
in self-reported BDI-II depressive symptoms, with cannabis users
reporting on average 2 more symptoms than controls, but still
within the minimal range of symptoms [F(1,66) = 4.24, p = .04].
Groups did not differ in ethnicity [22 Caucasian cannabis users
and 23 Caucasian controls [X2(4) = 3.86, p = .43], gender [X2(1) = 2.9,
p = .09], past year Cahalan alcohol drinking patterns criteria
[X2(5) = 4.3, p = .51], age [F(1,66) = .02, p = .90], WRAT-4 Read-
ing standard score [F(1,66) = .39, p = .54], education [F(1,66) = 3.6,
p = .06], annual income [F(1,66) = .17, p = .68], or body mass index
[F(1,65) = .46, p = .50].
3.1.2. Drug variables
Mann–Whitney U tests revealed signiﬁcant differences between
cannabis users and controls in past year nicotine (U = 244.5, p < .01),
recent nicotine use (U = 199.5, p ≤ .01), past year alcohol use
(U = 334.5, p = .003), past year cannabis use (U = 0.00, p ≤ .01), and
past year other drug use (measured as standardized hits or pills
of stimulants, ecstasy, inhalants, hallucinogens, sedatives and opi-
ates; U = 236, p ≤ .01). The cannabis group used more of these
substances in comparison to controls, although the other drug use
category was relatively low for the vast majority of the cannabis
users and our exclusion criteria consistent with ≤ 20 lifetime uses
of any drug category.
3.2. Gyriﬁcation results
3.2.1. Cannabis group
After controlling for WRAT-4 Reading scaled score, age, gen-
der, past year alcohol use, cotinine levels, and current depressive
symptoms, cannabis users demonstrated signiﬁcantly reduced
gyriﬁcation in bilateral medial PFC (Right: [t(59) = −2.9, beta = −.41,
p = .005; FDR corrected p = .02] and Left: [t(59) = −3.1, beta = −.45,
p = .003; FDR corrected p = .02]); bilateral frontal poles (Right:
[t(59) = −2.7, beta = −.38, p = .009; FDR corrected p = .02] and Left:
[t(59) = −3.1, beta = −.46, p = .003; FDR corrected p = .02]); and bilat-
eral ventral-medial PFC (Right: [t(59) = −2.8, beta = −.40, p = .006;
FDR corrected p = .02] and Left: [t(59) = −3.0, beta = −.44, p = .004;
FDR corrected p = .02]) (see Fig. 1).
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No signiﬁcant group differences were observed in LGI for
otal hemisphere (control region) (Right: [t(58) = −1.6, beta = −.25,
 = .11] and Left: [t(58) = −.62, beta = −.09, p = .54]); dorsolateral PFC
Right: [t(59) = .05, beta = .007, p = .96] and Left: [t(59) = 1.5, beta = .2,
 = .15]); ventral lateral PFC (Right: [t(59) = −1.5, beta = −.23, p = .13]
nd Left: [t(59) = −.7, beta = −.11, p = .49]); or bilateral inferior
arietal cortex (Right: [t(60) = −1.9, beta = −.28, p = .06] and Left
t(60) = −.41, beta = −.06, p = .69]). There were no regions where
annabis users showed signiﬁcant increases compared to controls.
.3. Surface area results
.3.1. Cannabis group
After controlling for WRAT-4 Reading scaled score, age, gen-
er, past year alcohol use, cotinine levels, and current depressive
ymptoms, cannabis users demonstrated signiﬁcantly reduced SA
n the left ventral medial [t(60) = −2.5, beta = −.35, p = .02; FDR cor-
ected p = .09], and left ventral lateral PFC [t(60) = −2.7, beta = −.32,
 = .008; FDR corrected p = .09], although these ﬁndings were only
arginally signiﬁcant after correcting for multiple comparisons. No
igniﬁcant group differences were observed in total hemisphere
control region) SA (Right: [t(59) = −1.1, beta = −.12, p = .26] and
eft: [t(59) = −1.9, beta = −.2, p = .07]); bilateral medial PFC (Right:
t(60) = −1.0, beta = −.12, p = .30] and Left: [t(60) = −1.8, beta = −.22,
 = .08]); bilateral dorsolateral PFC (Right: [t(60) = −.65, beta = −.07,
 = .52] and Left: [t(60) = −1.7, beta = −.19, p = .10]); right ventral
edial PFC [t(60) = −1.5, beta = −.21, p = .14]; right ventral lateral
FC [t(60) = −1.4, beta = −.16, p = .18]; or bilateral inferior pari-
tal (Right: [t(60) = −1.3, beta = −.15, p = .20] and Left: [t(60) = −.53,
eta = −.07, p = .60]).
.4. Brain–behavior results
.4.1. Cannabis group
Positive correlations were found between increased gyriﬁcation
nd improved LNS performance in the right medial PFC [r = .50,
 = 33, p = .003], right ventral medial PFC [r = .38, n = 33, p = .03] and
ight frontal pole [r = .46, n = 33, p = .007].
.4.2. Controls
No signiﬁcant correlations were observed between brain
egions that signiﬁcantly differed between groups and neuropsy-
hological performance in controls.
. Discussion
This study examined whether cannabis use status predicted pre-
rontal or parietal local gyriﬁcation index (LGI) and surface area
SA) in a sample of otherwise healthy adolescents and emerging
dults. Consistent with the predicted hypotheses, after controlling
or reading ability, age, gender, past year alcohol use, cotinine lev-
ls, and current depressive symptoms, cannabis users had reduced
GI in bilateral medial frontal, ventral medial, and frontal poles.
o signiﬁcant differences were found in hemispheric or inferior
arietal LGI, suggesting that aberrant gyriﬁcation may  be localized
o particular PFC regions in emerging adults. Further, group differ-
nces in SA in orbitofrontal areas were consistent with LGI ﬁndings,
ut did not pass correction for multiple comparisons.
Decreased gyriﬁcation in right medial, ventral medial, and
rontal pole regions, were associated with poorer performance on
omplex attention in cannabis users, suggesting that reduced gyri-
cation confers a functional deﬁcit. This is consistent with previous
tudies suggesting increased gyriﬁcation is associated with bet-
er cognitive functioning (Wallace et al., 2013) and may  reﬂect
mproved cognitive control (Luders et al., 2012).nitive Neuroscience 16 (2015) 46–53
Present ﬁndings are consistent with prior research demonstrat-
ing unique PFC surface morphology characteristics in cannabis
using youth (Mata et al., 2010). Speciﬁcally, Mata et al. (2010) found
reduced sulcal concavity in the PFC of cannabis users in comparison
to non-users and failed to ﬁnd global hemispheric differences in SA.
In the current study we found signiﬁcantly reduced LGI in medial,
ventral medial, and frontal poles in cannabis users compared to
controls. We  found no signiﬁcant differences in inferior parietal
LGI and marginal differences in SA, while in an overlapping sample
we previously reported subtle volume abnormalities in this region
(Price et al., 2015). Though we  did not examine the relationship
between either LGI or SA and other cortical measures in this study,
surface area, gyriﬁcation, and cortical thickness appear have dis-
tinct patterns in neurodevelopment from ages 6 to 22 (Raznahan
et al., 2011). We  also found unique patterns in cannabis effects
between two cortical morphometry measures; after controlling for
covariates including age and gender, results from the current study
suggest that frequent cannabis use may  inﬂuence LGI in a more dif-
fuse PFC distribution compared to SA since we  found only marginal
reductions of SA in two PFC regions (left: ventral lateral and ventral
medial PFC) among cannabis users compared to controls. There-
fore, while gyriﬁcation may  be partially related to gray matter
volume and SA, it likely reﬂects a novel measure of brain matu-
ration (Klein et al., 2014). Though Mata et al. (2010) did not ﬁnd
global hemispheric group differences in SA, perhaps the inﬂuence
of frequent cannabis use on SA is restricted to regions with later
SA development. Changes in global SA during late adolescents may
be primarily driven by reduced global gyriﬁcation index (Raznahan
et al., 2011) and may  differ from inﬂuences driving cortical thick-
ness maturation (Wierenga et al., 2014). Future studies may  want
to examine how cannabis use impacts neurodevelopment utilizing
multiple measures of cortical morphometry (LGI, cortical thickness,
volume, and SA).
Frequent cannabis-using youth report using cannabis to cope
with stressors or relax (Boys et al., 2001; Mitchell et al., 2007; Bonn-
Miller et al., 2007; Johnson et al., 2010; Benschop et al., 2015),
although continued use may  negatively impact regions underly-
ing healthy affective processing (Etkin et al., 2011). For example,
the medial portions of the PFC are implicated in self-referential
thought, regulation of stress response, autonomic regulation, emo-
tional processing, and social cognition (Urry et al., 2009; Somerville
et al., 2013; Bado et al., 2014; for reviews see Uddin et al., 2007;
Hänsel and von Känel, 2008). Ventral medial portions of the PFC
play a role in regulating amygdala activity, contextual decision-
making, fear response and extinction, anticipatory responses, and
social processing (Aoki et al., 2014; Lonsdorf et al., 2014; Rudorf and
Hare, 2014; Spoormaker et al., 2014; Motzkin et al., 2014, 2015).
Animal studies suggest that the inferior frontal regions also play
a vital role in insight or one’s ability to imagine consequences of
behavior in new situations (Lucantonio et al., 2012). The frontal
pole underlies detecting contextual change, and reward-related
decision-making (Pollmann and Manginelli, 2009; Kovach et al.,
2012). Therefore, additional studies examining functional conse-
quences of cannabis use in youth may  focus on affective processing,
reward processing, and mood symptomatology. In addition, given
the potential impact of endocannabinoid signaling on PFC acti-
vation (Filbey et al., 2010), future studies may want to examine
whether genotypes related to endocannabinoid signaling interact
with cannabis exposure to predict frontolimbic structural integrity
in youth.
Further, there is also evidence of functional abnormalities
as evidenced on fMRI studies of inhibitory control and complex
working memory (see Tapert et al., 2007; Schweinsburg et al.,
2008; Jacobsen et al., 2007). In an overlapping sample, our lab
previously reported smaller inferior parietal volumes with small
effect size among cannabis using emerging adults, although this
tal Cog
ﬁ
T
t
c
p
m
u
i
d
n
m
c
s
p
m
e
o
s
o
t
a
2
s
r
i
o
t
2
o
p
p
5
h
t
r
s
i
r
a
e
a
s
d
p
i
C
A
A
C
D
mS.G. Shollenbarger et al. / Developmen
nding did not survive multiple corrections (see Price et al., 2015).
aken together, later to develop PFC regions may  be more consis-
ently susceptible to morphological abnormalities associated with
annabis use during youth.
The current study was cross-sectional; therefore, it is not
ossible to determine whether the LGI and SA results reﬂect pre-
orbid characteristics that co-occur with the onset of cannabis
se. For example, there is evidence that smaller OFC volumes and
ncreased impulsivity predict earlier age of cannabis use onset
uring adolescence (Cheetham et al., 2012). However, there are
o studies to date that have examined whether other cortical
orphometric measures (SA or gyriﬁcation) predict the onset of
annabis use, so it is not known whether these measures are
ensitive premorbid markers for addiction risk, or cannabis use
otential. On the other hand, it is not known whether these
orphological features are more sensitive to environmental inﬂu-
nce later in the course of development compared to volume
r cortical thickness. Therefore, larger prospective longitudinal
tudies are needed to examine the inﬂuence of cannabis use
n multiple morphometric measures (volume, LGI, SA, cortical
hickness).
There are other limitations that need to be considered. Alcohol
nd cannabis use among youth are highly comorbid (Johnston et al.,
011). Although the current study excluded “very heavy” drinkers,
tatistically controlled for past year alcohol use, and did not ﬁnd any
elationship between past year alcohol use and gyriﬁcation or SA, it
s possible that some of the ﬁndings are associated with combined
r simultaneous cannabis and alcohol use. Lastly, due to the poten-
ial impact of various workstations on results (Gronenschild et al.,
012) results of the current study may  be speciﬁc to the particular
perating system, FreeSurfer version, imaging acquisition and pre-
rocessing. Thus, replication using different imaging parameters or
rocessing techniques is warranted.
. Conclusion
In conclusion, this study found that regular cannabis users
ad less complex PFC gyriﬁcation, especially in medial and ven-
ral medial regions. Cannabis users also demonstrated marginal
eductions in orbitofrontal surface area. Reduced gyriﬁcation was
igniﬁcantly correlated with poorer working memory. These ﬁnd-
ngs may  reﬂect alterations in synaptic connections, resulting in
educed prefrontal complexity and poorer cognitive functioning in
dolescent onset cannabis users. This adds to converging lines of
vidence that suggest that adolescence and emerging adulthood is
 sensitive period for drug-induced neurocognitive effects. Under-
tanding the impact of regular cannabis use on neurodevelopment
uring adolescence and emerging adulthood remains a signiﬁcant
ublic health priority and additional prospective longitudinal stud-
es are warranted.
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